Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Active gamma-carboxylated human factor IX expressed using recombinant DNA techniques.

H de la Salle, W Altenburger, R Elkaim

    Nature
    |July 18, 1985
    PubMed
    Summary

    Recombinant DNA techniques enabled the production of active human factor IX in hepatoma cells. This breakthrough offers a promising avenue for treating hemophilia B, a serious bleeding disorder.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Medium-term results of internal urinary diversion via sigmoido-rectal Mainz II pouch in case of irreparable vesico-vaginal obstetric fistula in Ouagadougou].

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
    Same author

    Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura.

    Vox sanguinis·2018
    Same author

    Retinoic acid receptor-α regulates synthetic events in human platelets: comment.

    Journal of thrombosis and haemostasis : JTH·2018
    Same author

    Platelets are dispensable for antibody-mediated transfusion-related acute lung injury in the mouse.

    Journal of thrombosis and haemostasis : JTH·2016
    Same author

    Purinergic receptors on blood platelets.

    Platelets·2010
    Same author

    Diets rich in saturated n-9 and n-3 fatty acids differentially affect the fatty acid composition of phospholipids and function of rat platelets.

    Platelets·2010

    Area of Science:

    • Biotechnology
    • Molecular Biology
    • Hematology

    Background:

    • Factor IX (Christmas factor) is crucial for blood coagulation.
    • Deficiency in Factor IX causes hemophilia B, a genetic bleeding disorder.
    • Current treatment involves Factor IX concentrates, with a need for improved production methods.

    Purpose of the Study:

    • To explore the use of recombinant DNA technology for producing functional human Factor IX.
    • To assess the efficacy of vaccinia virus-based vectors for expressing complex proteins.
    • To evaluate Factor IX production in different cell types.

    Main Methods:

    • A human Factor IX cDNA clone was inserted into a vaccinia virus vector.
    • The recombinant vector was used to infect human hepatoma cells and mouse fibroblasts.

    Related Experiment Videos

  • Factor IX activity was measured in the produced proteins.

    • Main Results:

    • Human hepatoma cells successfully produced fully active Factor IX.
    • Mouse fibroblasts produced a less active form of Factor IX, irrespective of vitamin K levels.
    • This demonstrates the successful expression of a complex, post-translationally modified protein via recombinant DNA technology.

    Conclusions:

    • Vaccinia virus-based vectors can efficiently express active, complex therapeutic proteins like Factor IX in eukaryotic cells.
    • This approach holds significant potential for the large-scale production of Factor IX for hemophilia B treatment.
    • The study highlights the advancement in recombinant protein production for clinical applications.